Olon ist bereit für die Produktion in der neuen Anlage für hoch starke Wirkstoffe
November 04, 2024 05:00 ET
|
Olon SpA
MAILAND, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Olon, ein Arzneimittelhersteller und globales CDMO-Unternehmen, bestätigt den Zeitplan für den Bau seiner neuen Produktionsanlage für hoch starke...
Olon est prête à lancer la production dans sa nouvelle installation dédiée aux composés ultra-puissants
November 04, 2024 05:00 ET
|
Olon SpA
MILAN, 04 nov. 2024 (GLOBE NEWSWIRE) -- Olon, fournisseur d’API et acteur mondial dans le domaine des CDMO, confirme le respect du calendrier de construction de sa nouvelle installation dédiée aux...
Olon is ready to host productions in the new facility dedicated to ultra-potent compounds
November 04, 2024 05:00 ET
|
Olon SpA
Olon is ready to host productions
in the new facility dedicated to ultra-potent compounds
High Potency APIs (HPAPIs) Strategic Research Report 2024: Global Market to Reach $46.9 Billion by 2030, Driven by Expansion of Oncology, Hormonal, and Endocrine Therapies
October 10, 2024 11:02 ET
|
Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "High Potency APIs (HPAPIs) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for High...
Asia-Pacific CDMO Market Share Analysis, Industry Trends & Growth Forecasts 2024-2029: Demand For Injectable Dose Formulation is Rising in the Market
September 23, 2024 05:47 ET
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)" report has been added to ...
Active Pharmaceutical Ingredients (API) Business Research Report 2024: Market to Reach $358.5 Billion by 2030 - North America Dominates, China Continues to Remain a Major Hub
August 30, 2024 07:22 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients (API) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
Asia-Pacific Highly Potent API Industry Research 2023-2033: Containment Technology Advances, Increasing Investment for Manufacturing Units, Pharma Companies Outsourcing HPAPIs Production to CDMOs
July 22, 2024 06:16 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Highly Potent API Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The...
Highly Potent Active Pharmaceutical Ingredients (HPAPIs) Market Report 2024-2034
July 11, 2024 10:42 ET
|
Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "Highly Potent Active Pharmaceutical Ingredients (HPAPIs) Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue...
Europe Highly Potent API Market Analysis 2023-2033 with Almac, Axplora, BASF, CordenPharma, Helsinn Healthcare, ICROM, Lonza, Merck, & Sterling Pharma Solutions Dominating the $16 Billion Industry
July 01, 2024 05:29 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Europe Highly Potent API Market - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Europe highly...
Global High Potency API Contract Manufacturing Market Expects Growth with a CAGR of 8.42% Through 2028
April 02, 2024 12:58 ET
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "High Potency API (HPAPI) Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been...